MiNK Therapeutics, Inc. (INKT) Stock price, Description, News & Info

#Thinksabio latest news

MiNK Therapeutics to Present Late-Breaking Data on AgenT-797 in Solid Tumors at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting